Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Autoimmune Disorders

Free Subscription 04.05.2025 1 Ann Neurol 1 Diabet Med 2 Intern Med 1 J Clin Endocrinol Metab 1 J Immunol 3 J Neuroimmunol 4 J Neurol 3 J Rheumatol 1 Kidney Int 5 Mult Scler 1 Neurologia (Engl Ed) 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. POOLE S, Sisodia N, Koshal K, Henderson K, et al
   Detecting New Lesions Using a Large Language Model: Applications in Real-World Multiple Sclerosis Datasets.
   Ann Neurol. 2025 Apr 25. doi: 10.1002/ana.27251.
   PubMed         Abstract available
   
   

   
   Diabet Med

2. SANKARESWARAN A, Kunte P, Fraser DP, Shaik M, et al
   HLA haplotype diversity, islet autoantibody status and discriminative ability of type 1 diabetes genetic risk score in Indians.
   Diabet Med. 2025 Apr 25:e70041. doi: 10.1111/dme.70041.
   PubMed         Abstract available
   
   

   
   Intern Med

3. JUBASHI T, Tomokawa T, Hara K, Horai Y, et al
   Effectiveness and Safety of Avacopan as a Combination Therapy with Glucocorticoids or Monotherapy in Patients with Microscopic Polyangiitis.
   Intern Med. 2025;64:1427-1433.
   PubMed         Abstract available
   
   
4. YAMANE T, Hashiramoto A
   Solo Addition of Mepolizumab Turned Antineutrophil Cytoplasmic Antibody Negative and Achieved Glucocorticoid Discontinuation in a Patient with Eosinophilic Granulomatosis with Polyangiitis.
   Intern Med. 2025;64:1423-1426.
   PubMed         Abstract available
   
   

   
   J Clin Endocrinol Metab

5. BUJNIS M, DeSalvo K, Neklason DW, Madsen MJ, et al
   Familial risk of Hashimoto's thyroiditis in a large genealogical database.
   J Clin Endocrinol Metab. 2025 Apr 28:dgaf251. doi: 10.1210.
   PubMed         Abstract available
   
   

   
   J Immunol

6. TURICEK DP, Wan X
   Decoding autoimmunity: HLA-DQbeta and type 1 diabetes.
   J Immunol. 2025 Apr 28:vkaf070. doi: 10.1093.
   PubMed        
   
   

   
   J Neuroimmunol

7. DEFFENBAUGH JL, Jung KJ, Murphy SP, Liu Y, et al
   Corrigendum to "Novel model of multiple sclerosis induced by EBV-like virus generate a unique B cell population" [Journal of Neuroimmunology volume 394 (2024) 578408].
   J Neuroimmunol. 2025;404:578625.
   PubMed        
   
   
8. ONISHI Y, Uzawa A, Yasuda M, Akamine H, et al
   Elevated serum levels of IL-10 family and IL-12 family cytokines in myasthenia gravis.
   J Neuroimmunol. 2025;404:578621.
   PubMed         Abstract available
   
   
9. MASI F, Al Qudsi S, Visigalli D, Zardini E, et al
   Oligoclonal IgM band patterns in multiple sclerosis: A two-center study.
   J Neuroimmunol. 2025;404:578622.
   PubMed         Abstract available
   
   

   
   J Neurol

10. KUUTTI K, Laakso SM, Viitala M, Atula S, et al
    Mortality and causes of death for people with multiple sclerosis: a Finnish nationwide register study.
    J Neurol. 2025;272:370.
    PubMed         Abstract available
    
    
11. SEERY N, Wesselingh R, Beech P, Broadley J, et al
    Multimodal prognostication of autoimmune encephalitis: an Australian autoimmune encephalitis consortium study.
    J Neurol. 2025;272:361.
    PubMed         Abstract available
    
    
12. CACCIAGUERRA L, Madhavan A, Sechi E, Krecke KN, et al
    Utility of spinal cord axial-T2 sequence in a population-based cohort of multiple sclerosis.
    J Neurol. 2025;272:367.
    PubMed        
    
    
13. PANE C, Di Stefano V, Cuomo N, Sarnataro A, et al
    Correction: A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients.
    J Neurol. 2025;272:366.
    PubMed        
    
    

    
    J Rheumatol

14. KIM H
    Interferon Response Gene Score in Juvenile Dermatomyositis.
    J Rheumatol. 2025 May 1:jrheum.2025-0395. doi: 10.3899/jrheum.2025-0395.
    PubMed        
    
    
15. PATTERSON SL, Ruvalcaba D, Issa A, Rai K, et al
    Experiences with Complementary and Integrative Health Among People with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Qualitative Study.
    J Rheumatol. 2025 May 1:jrheum.2024-1218. doi: 10.3899/jrheum.2024-1218.
    PubMed         Abstract available
    
    
16. PLANTINGA LC, Roberts ET, Hoge C, Pearce BD, et al
    Indicators of Functional Disability by Receipt of Disability Benefits Among Individuals With Systemic Lupus Erythematosus.
    J Rheumatol. 2025;52:479-488.
    PubMed         Abstract available
    
    

    
    Kidney Int

17. OSTENDORF L, Rao DA
    ILC1s drive tissue-aggressive macrophages in experimental lupus nephritis.
    Kidney Int. 2025 Apr 28:S0085-2538(25)00262-5. doi: 10.1016/j.kint.2025.
    PubMed        
    
    

    
    Mult Scler

18. PILOTTO S, Pontieri L, Nielsen HH, Rasmussen PV, et al
    Pediatric Onset Multiple Sclerosis (POMS): Exploring phenotypic characterization and pubertal influences in modulating the disease activity from the Danish MS Registry (DMSR).
    Mult Scler. 2025 Apr 28:13524585251335476. doi: 10.1177/13524585251335476.
    PubMed         Abstract available
    
    
19. MADILL E, Moreira Ferreira V, Healy B, Zurawski J, et al
    Change in serum neurofilament light chain and glial fibrillary acidic protein levels with high-efficacy and low-efficacy early therapy in multiple sclerosis.
    Mult Scler. 2025 Apr 28:13524585251335521. doi: 10.1177/13524585251335521.
    PubMed         Abstract available
    
    
20. STEPHENS S, Iseyas N, Yeh EA
    Physical activity demonstrates protective associations with structural visual metrics in children with multiple sclerosis through time.
    Mult Scler. 2025 Apr 28:13524585251335510. doi: 10.1177/13524585251335510.
    PubMed         Abstract available
    
    
21. YALDIZLI O, Benkert P, Achtnichts L, Bar-Or A, et al
    Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study.
    Mult Scler. 2025 Apr 28:13524585251335466. doi: 10.1177/13524585251335466.
    PubMed         Abstract available
    
    
22. FERRAZZANO G, Maccarrone D, Guerra A, Collura A, et al
    The effects of gamma-tACS on cognitive impairment in multiple sclerosis: A randomized, double-blind, sham-controlled, pilot study.
    Mult Scler. 2025 Apr 26:13524585251333575. doi: 10.1177/13524585251333575.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

23. RODRIGUEZ DE ANTONIO LA, Fernandez de Cordoba-Garcia R, Herrero-Munoz N, Ontanon-Nasarre A, et al
    Treatment adherence in patients with multiple sclerosis: Risk factors.
    Neurologia (Engl Ed). 2025 Apr 25:S2173-5808(25)00036.
    PubMed         Abstract available
    
    

    
    PLoS One

24. YIN J, Hou Y, Wang C, Qin C, et al
    Clinical outcomes of baricitinib in patients with systemic lupus erythematosus: Pooled analysis of SLE-BRAVE-I and SLE-BRAVE-II trials.
    PLoS One. 2025;20:e0320179.
    PubMed         Abstract available
    
    
25. HE S, Nie H, Yin X, Zhong Z, et al
    Identification of key extracellular proteins as the potential biomarkers in thyroid eye disease.
    PLoS One. 2025;20:e0322415.
    PubMed         Abstract available
    
    
26. MENG H, Wang S, Gu L, Wang Y, et al
    Potential drug targets for Neuromyelitis optica spectrum disorders (NMOSD): A Mendelian randomization analysis.
    PLoS One. 2025;20:e0322098.
    PubMed         Abstract available
    
    
27. ALAZWARI A, Tafakori L, Johnstone A, Abdollahian M, et al
    Modeling the number of new cases of childhood type 1 diabetes using Poisson regression and machine learning methods; a case study in Saudi Arabia.
    PLoS One. 2025;20:e0321480.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.